JCM Figure table search 04
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Brinkman, J. A.
Right arrow Articles by Hagensee, M. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brinkman, J. A.
Right arrow Articles by Hagensee, M. E.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, September 2002, p. 3155-3161, Vol. 40, No. 9
0095-1137/02/$04.00+0     DOI: 10.1128/JCM.40.9.3155-3161.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.

Detection of Human Papillomavirus DNA in Urine Specimens from Human Immunodeficiency Virus-Positive Women

Joeli A. Brinkman,1* W. Elizabeth Jones,1,{dagger} Ann M. Gaffga,1 Jonathan A. Sanders,1 Anil K. Chaturvedi,2 Joseph Slavinsky III,2 John L. Clayton,2 Jeanne Dumestre,3 and Michael E. Hagensee3

Department of Microbiology,1 Department of Medicine, Louisiana State University Health Sciences Center ,3 Department of Epidemiology, Tulane University, New Orleans, Louisiana2

Received 7 November 2001/ Returned for modification 11 February 2002/ Accepted 7 June 2002

Human immunodeficiency virus (HIV)-positive women may represent one of the fastest-growing populations at risk for acquiring cervical cancer and thus require frequent screening. The purpose of the present studies was to validate a PCR-based urine assay by comparing detection and genotyping of human papillomavirus (HPV) DNA in urine samples and matching cervical swab specimens of HIV-positive women. Despite a difference in amplifiability, the prevalence of any HPV genotype (58% for the cervical swab specimens and 48% for the urine specimens) was not significantly different in this population. The levels of concordance were 70, 71, and 78% for detection of any HPV type, any high-risk HPV type, or any low-risk HPV type in the two specimen types, respectively. While instances of discordant detection were greater for the cervical swab specimens than for the urine specimens, this was not statistically significant. The distributions of HPV genotypes were similar in the cervix and the urine for the majority of types examined. Importantly, detection of HPV DNA in urine was associated with an abnormal Papanicolaou smear to the same extent that detection of HPV DNA in a cervical swab specimen was. These data provide preliminary support for the proposal to use urine testing as a primary or secondary screening tool for cervical cancer in HIV-positive women or as an epidemiological tool. Additional studies with larger sample sizes must be conducted in order to further verify these findings.

* Corresponding author. Mailing address: Department of Microbiology, LSU Health Science Center, 1901 Perdido St., New Orleans, LA 70112-2822. Phone: (504) 568-4398. Fax: (504) 568-2918. E-mail: jbrink{at}lsuhsc.edu.

{dagger} Present address: University of Wisconsin, Madison.

Journal of Clinical Microbiology, September 2002, p. 3155-3161, Vol. 40, No. 9
0095-1137/02/$04.00+0     DOI: 10.1128/JCM.40.9.3155-3161.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:



Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Antimicrob. Agents Chemother. Clin. Microbiol. Rev.
Clin. Vaccine Immunol. ALL ASM JOURNALS

Copyright © 2002 by the American Society for Microbiology. All rights reserved.